(Q41675353)

6 October 2017

Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

1 reference

ten Bokkel Huinink D

7

1 reference

6 October 2017

G. Los

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

E. Verdegaal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

H. P. Noteborn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

M. Ruevekamp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

A. de Graeff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

E. W. Meesters

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

D. ten Bokkel Huinink

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

J. G. McVie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859450

11 December 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

6 October 2017

5 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1859450

full work available at URL

11 December 2022

https://api.elsevier.com/content/article/PII:000629529190723I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

https://api.elsevier.com/content/article/PII:000629529190723I?httpAccept=text/plain

11 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

published in

Biochemical Pharmacology

1 reference

6 October 2017

42

1 reference

6 October 2017

2

1 reference

6 October 2017

357-363

1 reference

Cisplatin (cis-diamminedichloroplatinum II)

6 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

High dose cisplatin and high dose carboplatin in refractory ovarian cancer.

11 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Review of the current clinical status of platinum coordination complexes in cancer chemotherapy

11 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Antitumor activity against human tumor samples of cis-diamminedichloroplatinum(II) and analogues at equivalent in vitro myelotoxic concentrations

11 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Nephrotoxicity of cis-dichlorodiammineplatinum(II)

11 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

Platinum nephrotoxicity

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Drugs five years later. Cisplatin

11 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Fundamental studies with cisplatin

11 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Intraperitoneal cisplatin with systemic thiosulfate protection

11 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

11 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Ovarian trials at the Royal Marsden.

11 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

cis-Diamminedichloroplatinum(II): effects of a representative metal coordination complex on mammalian cells

11 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Pharmacokinetics of carboplatin after intraperitoneal administration

11 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Phase I study and pharmacokinetics of intraperitoneal carboplatin

11 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

Aspects of cytotoxic drug penetration, with particular reference to anthracyclines

11 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay

11 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90723-I

11 December 2022

Identifiers

1 reference

6 October 2017

1 reference